APA (7th ed.) Citation

M, T., C, L., A, T., Z, G., D, T., D, J., . . . CL, B. (2026). Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): A randomised, double-blind, multicentre, placebo-controlled, phase 3 trial. The lancet. Gastroenterology & hepatology, 11(1), 46. https://doi.org/10.1016/S2468-1253(25)00208-0

Chicago Style (17th ed.) Citation

M, Trauner, et al. "Cilofexor in Non-cirrhotic Primary Sclerosing Cholangitis (PRIMIS): A Randomised, Double-blind, Multicentre, Placebo-controlled, Phase 3 Trial." The Lancet. Gastroenterology & Hepatology 11, no. 1 (2026): 46. https://doi.org/10.1016/S2468-1253(25)00208-0.

MLA (9th ed.) Citation

M, Trauner, et al. "Cilofexor in Non-cirrhotic Primary Sclerosing Cholangitis (PRIMIS): A Randomised, Double-blind, Multicentre, Placebo-controlled, Phase 3 Trial." The Lancet. Gastroenterology & Hepatology, vol. 11, no. 1, 2026, p. 46, https://doi.org/10.1016/S2468-1253(25)00208-0.